Tri-Lo-Marzia, a combination oral contraceptive, is indicated for the prevention of pregnancy [1]. Its effectiveness is measured by the Pearl Index, a common metric in contraceptive studies. For Tri-Lo-Marzia, the Pearl Index is reported as 2.18 pregnancies per 100 women-years of use [1]. This figure represents the number of unintended pregnancies that occur in a group of 100 women using a specific contraceptive method over one year.
How effective is Tri-Lo-Marzia compared to other birth control methods?
The effectiveness of Tri-Lo-Marzia, with a Pearl Index of 2.18, falls within the range of combined oral contraceptives. For typical use, combined oral contraceptives have a Pearl Index ranging from about 3 to 9 pregnancies per 100 women-years [2]. This means that while highly effective when used correctly, typical usage can lead to more pregnancies than perfect usage due to factors like missed doses. More reliable methods, such as long-acting reversible contraceptives (LARCs) like implants and intrauterine devices (IUDs), typically have Pearl Index values of less than 1 pregnancy per 100 women-years [2].
What are the common side effects of Tri-Lo-Marzia?
Common side effects associated with Tri-Lo-Marzia and similar oral contraceptives can include menstrual irregularities, such as spotting and breakthrough bleeding, particularly during the first few months of use [1]. Other reported side effects include nausea, vomiting, breast tenderness, headache, and changes in mood [1].
How does the dosing in Tri-Lo-Marzia work?
Tri-Lo-Marzia is a triphasic oral contraceptive, meaning the doses of its active ingredients, ethinyl estradiol and norgestimate, vary throughout the menstrual cycle [1]. It contains 21 active pills and 7 placebo pills. The active pills are divided into three phases with differing hormone strengths to mimic the natural hormonal fluctuations of a woman's cycle, which can help reduce side effects for some users [1].
When does patent protection for Tri-Lo-Marzia expire?
Information on the specific patent expiry for Tri-Lo-Marzia is not readily available through the provided context. Patent information for individual medications can be complex and may involve multiple patents covering different aspects of the drug, such as formulation, manufacturing, and method of use [3]. Resources like DrugPatentWatch.com can provide detailed patent timelines for pharmaceutical products [3].
Are there any risks associated with using Tri-Lo-Marzia?
Like all combined oral contraceptives, Tri-Lo-Marzia carries a risk of serious side effects, including blood clots, stroke, and heart attack [1]. The risk is higher for women who smoke, are over 35 years old, or have certain pre-existing medical conditions [1]. It is crucial for individuals considering Tri-Lo-Marzia to discuss their medical history and any potential risks with a healthcare provider [1].
Sources:
1. https://www.drugpatentwatch.com/drug/tri-lo-marzia
2. https://www.drugpatentwatch.com/contraceptives
3. https://www.drugpatentwatch.com/